These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 21397335)

  • 1. Recurrence of bipolar mania is associated with catechol-O-methyltransferase Val(108/158)Met polymorphism.
    Benedetti F; Dallaspezia S; Locatelli C; Radaelli D; Poletti S; Lorenzi C; Pirovano A; Colombo C; Smeraldi E
    J Affect Disord; 2011 Jul; 132(1-2):293-6. PubMed ID: 21397335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between catechol-O-methyltransferase Val(108/158)Met polymorphism and psychotic features of bipolar disorder.
    Benedetti F; Dallaspezia S; Colombo C; Lorenzi C; Pirovano A; Smeraldi E
    J Affect Disord; 2010 Sep; 125(1-3):341-4. PubMed ID: 20122740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute antidepressant response to sleep deprivation combined with light therapy is influenced by the catechol-O-methyltransferase Val(108/158)Met polymorphism.
    Benedetti F; Barbini B; Bernasconi A; Fulgosi MC; Dallaspezia S; Gavinelli C; Locatelli C; Lorenzi C; Pirovano A; Radaelli D; Smeraldi E; Colombo C
    J Affect Disord; 2010 Feb; 121(1-2):68-72. PubMed ID: 19520435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COMT polymorphisms as predictors of cognitive dysfunction during manic and mixed episodes in bipolar I disorder.
    Soeiro-de-Souza MG; Machado-Vieira R; Soares Bio D; Do Prado CM; Moreno RA
    Bipolar Disord; 2012 Aug; 14(5):554-64. PubMed ID: 22713126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COMT genotype increases risk for bipolar I disorder and influences neurocognitive performance.
    Burdick KE; Funke B; Goldberg JF; Bates JA; Jaeger J; Kucherlapati R; Malhotra AK
    Bipolar Disord; 2007 Jun; 9(4):370-6. PubMed ID: 17547583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COMT and age at onset in mood disorders: a replication and extension study.
    Massat I; Kocabas NA; Crisafulli C; Chiesa A; Calati R; Linotte S; Kasper S; Fink M; Antonijevic I; Forray C; Snyder L; Bollen J; Zohar J; De Ronchi D; Souery D; Serretti A; Mendlewicz J
    Neurosci Lett; 2011 Jul; 498(3):218-21. PubMed ID: 21600957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
    Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of COMT, 5-HT(1A) , and SERT genetic polymorphisms on antidepressant response to Transcranial Magnetic Stimulation.
    Malaguti A; Rossini D; Lucca A; Magri L; Lorenzi C; Pirovano A; Colombo C; Smeraldi E; Zanardi R
    Depress Anxiety; 2011 Jul; 28(7):568-73. PubMed ID: 21449006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Catechol-O-methyltransferase gene and obsessive-compulsive symptoms in patients with recent-onset schizophrenia: preliminary results.
    Zinkstok J; van Nimwegen L; van Amelsvoort T; de Haan L; Yusuf MA; Baas F; Linszen D
    Psychiatry Res; 2008 Jan; 157(1-3):1-8. PubMed ID: 17850881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catechol-O-methyltransferase Val158Met polymorphism affects therapeutic response to mood stabilizer in symptomatic manic patients.
    Lee HY; Kim YK
    Psychiatry Res; 2010 Jan; 175(1-2):63-6. PubMed ID: 20004480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic susceptibility of catechol-O-methyltransferase polymorphism in Japanese patients with breast cancer.
    Inoue H; Shibuta K; Matsuyama A; Yoshinaga K; Sadanaga N; Ueo H; Barnard GF; Mori M
    Oncol Rep; 2005 Sep; 14(3):707-12. PubMed ID: 16077979
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Manic symptom severity correlates with COMT activity in the striatum: A post-mortem study.
    Bortolato M; Walss-Bass C; Thompson PM; Moskovitz J
    World J Biol Psychiatry; 2017 Apr; 18(3):247-254. PubMed ID: 27458023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical involvement of catechol-O-methyltransferase polymorphisms in schizophrenia spectrum disorders: influence on the severity of psychotic symptoms and on the response to neuroleptic treatment.
    Molero P; Ortuño F; Zalacain M; Patiño-García A
    Pharmacogenomics J; 2007 Dec; 7(6):418-26. PubMed ID: 17363961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The COMT and DRD3 genes interacted in bipolar I but not bipolar II disorder.
    Lee SY; Chen SL; Chen SH; Huang SY; Tzeng NS; Chang YH; Wang CL; Lee IH; Yeh TL; Yang YK; Lu RB
    World J Biol Psychiatry; 2011 Aug; 12(5):385-91. PubMed ID: 20698735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensory gating deficit is associated with catechol-O-methyltransferase polymorphisms in bipolar disorder.
    Ancín I; Cabranes JA; Vázquez-Álvarez B; Santos JL; Sánchez-Morla E; García-Jiménez MÁ; Fernández C; Barabash A
    World J Biol Psychiatry; 2011 Aug; 12(5):376-84. PubMed ID: 21595525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COMT gene val158met polymorphism in patients with dyspeptic symptoms.
    Tahara T; Arisawa T; Shibata T; Nakamura M; Wang F; Hirata I
    Hepatogastroenterology; 2008; 55(84):979-82. PubMed ID: 18705311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catechol-O-Methyltransferase (COMT) Val158Met variations and cannabis use in first-episode non-affective psychosis: clinical-onset implications.
    Pelayo-Terán JM; Pérez-Iglesias R; Mata I; Carrasco-Marín E; Vázquez-Barquero JL; Crespo-Facorro B
    Psychiatry Res; 2010 Oct; 179(3):291-6. PubMed ID: 20493536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catechol O-methyltransferase and monoamine oxidase A genotypes, and plasma catecholamine metabolites in bipolar and schizophrenic patients.
    Zumárraga M; Dávila R; Basterreche N; Arrue A; Goienetxea B; Zamalloa MI; Erkoreka L; Bustamante S; Inchausti L; González-Torres MA; Guimón J
    Neurochem Int; 2010; 56(6-7):774-9. PubMed ID: 20206656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sympathetic nervous function and the effect of the catechol-O-methyltransferase Val(158)Met polymorphism in patients with panic disorder.
    Kang EH; Song YJ; Kim KJ; Shim HB; Park JE; Yu BH
    J Affect Disord; 2010 Jun; 123(1-3):337-40. PubMed ID: 19900710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine 2 receptor C957T and catechol-o-methyltransferase Val158Met polymorphisms are associated with treatment response in electroconvulsive therapy.
    Huuhka K; Anttila S; Huuhka M; Hietala J; Huhtala H; Mononen N; Lehtimäki T; Leinonen E
    Neurosci Lett; 2008 Dec; 448(1):79-83. PubMed ID: 18929622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.